| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Nov 19, 2025 | RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer | Sell | 42.5 | -17,584 | -2.33% | ✗ | $72.8K |
| Aug 15, 2025 | Aug 19, 2025 | RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer | Sell | 42.5 | -40,388 | -5.70% | ✗ | $223.5K |
| May 15, 2025 | May 19, 2025 | RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer | Sell | 48.8 | -3,796 | -0.53% | ✗ | $16.1K |
| Feb 3, 2025 | Feb 5, 2025 | RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer | Sell | 91.3 | +215,409 | 43.34% | ✗ | $20K |